When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation?


Like Comment

Volume 109, Issue 4, Pages 611–612


Jacqueline Y. Maher, M.D., James Segars, M.D.


Reflections on "Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review" by Alviggi et al.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.